Drug
Brolucizumab
Brolucizumab: highest development phase Phase 3, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Brolucizumab 6 mg NCT04005352 | Phase 3 | Age-related Macular Degeneration |
Latest
No recent events.
Follow Brolucizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.